Amgen to Build $200M Singapore Drug Facility

Biotechnology company Amgen Inc. plans to spend $200 million over the next several years to build a new antibody manufacturing facility in Singapore.
Jan. 21, 2013
Sign up for Pharma Manufacturing Newsletters
Get the latest news and updates

Related

Eli Lilly’s new Concord, North Carolina site was built with NASCAR-like speed
Celltrion to buy US biologics manufacturing plant as part of tariff response strategy
OnTrak Wireless: Total Bearing Health Solution
Sponsored
OnTrak Wireless & UltraTrak Vario Lubricators: Bearing Health Unified
Sponsored